Rchr
J-GLOBAL ID:201801010423557234
Update date: Sep. 18, 2022
Okamoto Wataru
オカモト ワタル | Okamoto Wataru
Contact this researcher
You can send email directly to the researcher.
Affiliation and department:
-
About -
Search "-"
Papers (33):
Harada K, Okamoto W, Mimaki S, Kawamoto Y, Bando H, Yamashita R, Yuki S, Yoshino T, Komatsu Y, Ohtsu A, et al. Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy. BMC cancer. 2019. 19. 1. 255-255
Taniguchi H, Okamoto W, Muro K, Akagi K, Hara H, Nishina T, Kajiwara T, Denda T, Hironaka S, Kudo T, et al. Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study. Neoplasia (New York, N.Y.). 2018. 20. 12. 1219-1226
Bando H, Okamoto W, Fukui T, Yamanaka T, Akagi K, Yoshino T. Utility of the Quasi-monomorphic Variation Range in Unresectable Metastatic Colorectal Cancer Patients. Cancer science. 2018. 109. 11. 3411-3415
Yoichi Naito, Hideaki Takahashi, Kohei Shitara, Wataru Okamoto, Hideaki Bando, Takeshi Kuwata, Yasutoshi Kuboki, Shingo Matsumoto, Izumi Miki, Takeharu Yamanaka, et al. Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study. Japanese Journal of Clinical Oncology. 2018. 48. 6. 559-564
Kentaro Sawada, Yoshiaki Nakamura, Takeharu Yamanaka, Yasutoshi Kuboki, Daisuke Yamaguchi, Satoshi Yuki, Takayuki Yoshino, Yoshito Komatsu, Naoya Sakamoto, Wataru Okamoto, et al. Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 2018. 17. 3. 198-205
more...
MISC (129):
岡本渉. Construction of Clinico-Genomic Database. Progress in Medicine. 2018. 38. 9. 987-991
岡本渉. Utilization of Patient Registry for development of anti-cancer drugs; from a standpoint of academia: SCRUM-Japan Registry. 月刊腫瘍内科. 2018. 22. 2. 234-237
藤井誠志, MAGLIOCCO Anthony, VALTORTA Emanuele, 澤田憲太郎, 中村能章, 岡本渉, 土原一哉, 吉野孝之. HER2陽性大腸癌に対する国際協調診断基準の策定と新たなNGS利用の展望. 日本病理学会会誌. 2018. 107. 1. 301
岡本渉. 多施設共同スクリーニングプロジェクト(SCRUM-Japan)における病理医の意義と期待される役割. 日本病理学会会誌. 2018. 107. 1. 197
大場 彬博, 森実 千種, 岡本 渉, 吉野 孝之. 【Precision medicineをめざした胆道・膵悪性腫瘍ゲノム医療の最前線】 膵癌・胆道癌に対するクリニカルシーケンス SCRUM-Japanの取り組み. 胆と膵. 2018. 39. 4. 343-347
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM